Yahoo Web Search

Search results

1. www.linkedin.com › in › andrew-greenspan-md-b6a4a8122Andrew Greenspan, MD - Johnson & Johnson Innovative Medicine ...

   www.linkedin.com › in › andrew-greenspan-md-b6a4a8122

   Johnson & Johnson Innovative Medicine. Raritan, New Jersey, United States. Education. Harvard Medical School. 1992 - 1996. 1986 - 1990. More activity by Andrew. For US #HCPs at the ESMO -...

   • Connections: 500+
   • Works For: Johnson & Johnson Innovative Medicine

   • Followers: 2.5K
   • Location: Raritan, New Jersey, United States

2. medicalaffairs.org › leadership › andy-greenspanAndy Greenspan – Medical Affairs Professional Society

   medicalaffairs.org › leadership › andy-greenspan

   • Cached

   Andrew is currently the Chief Global Medical Affairs Officer for Janssen. Prior to this position, and as Vice President of Immunology Medical Affairs, Andrew was responsible for leadership and oversight of Immunology Medical Affairs activities supporting REMICADE®, SIMPONI®, SIMPONI ARIA®, STELARA® and TREMFYA® for a wide range of diseases ...

3. www.pharmashots.com › 7741 › pharmashots-interviewPharmaShots Interview: Janssen's Andrew Greenspan Shares ...

   www.pharmashots.com › 7741 › pharmashots-interview

   • Cached

   In a recent interview with PharmaShots, Andrew Greenspan, MD, VP Medical Affairs of Janssen Immunology shared his views on Janssen's commitment to advance research in rheumatic disease. Shots: Janssen presented clinical trial results in 35 abstracts featuring findings across PsA, RA, and SLE at ACR Convergence 2020 Virtual Scientific Program

4. www.jnj.com › media-center › press-releasesJANSSEN ANNOUNCES U.S. FDA APPROVAL OF TREMFYA™ (GUSELKUMAB ...

   www.jnj.com › media-center › press-releases

   • Cached

   Jul 13, 2017 · “Addressing the need for additional safe and effective plaque psoriasis therapies has been a critical area of focus at Janssen for more than 15 years,” said Andrew Greenspan, M.D., Vice President of Medical Affairs at Janssen.

5. Images

   • 
   • 
   • 
   • 
   • 

   View all

6. www.fiercepharma.com › pharma › by-solving-axialJohnson & Johnson's Tremfya eyes bigger psoriatic arthritis ...

   www.fiercepharma.com › pharma › by-solving-axial

   • Cached

   Jun 29, 2021 · “The fact that we are bringing out new evidence for its efficacy, particularly for these patients with this axial manifestations, really underscores the unique benefits that Tremfya provides for...

   • Author: Kevin Dunleavy

7. www.janssen.com › blogs › tackling-stigma-plaquePlaque Psoriasis | Janssen

   www.janssen.com › blogs › tackling-stigma-plaque

   • Cached

   Andrew Greenspan, M.D. As Vice President of Immunology Medical Affairs, Andrew is responsible for leadership and oversight of Immunology Medical Affairs activities supporting treatments across a wide range of diseases, including Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis and Psoriasis.

8. www.jnj.com › media-center › press-releasesJANSSEN RECEIVES TWO U.S. FDA APPROVALS FOR SIMPONI ARIA ...

   www.jnj.com › media-center › press-releases

   • Cached

   Oct 20, 2017 · “Over the past 20+ years, Janssen has been pioneers in addressing the unmet needs of patients living with rheumatologic diseases like psoriatic arthritis and ankylosing spondylitis,” said Andrew Greenspan, M.D., Vice President of Medical Affairs at Janssen Scientific Affairs, LLC.